UNK GEL BREAST IMPLANT
Report
- Report Number
- 9617229-2019-10830
- Event Type
- Death
- Date Received
- August 9, 2019
- Report Date
- November 12, 2019
- Manufacturer
- ALLERGAN (COSTA RICA)
- Product Code
- FTR
- PMA / PMN Number
- P020056
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
IN RESPONSE TO FDA REPORT NUMBER: MW5087744. THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. REASON FOR REOPERATION: LYMPHOMA. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.
THE EVENTS OF ALCL-LYMPHOMA AND LYMPHADENOPATHY ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS.
REGULATORY AGENCY REPORTED CAUSE OF DEATH IS SEPSIS, MULTI ORGAN FAILURE DUE TO ALCL. UNKNOWN SIDE. UNKNOWN IF DEVICE WAS EXPLANTED.
HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED "PATIENT NOTICED A TUMOR INSIDE THE LEFT BREAST AND ALSO ENLARGED LYMPH NODES IN THE AXILLA. PATIENT ALSO NOTED B SYMPTOMS AND OVERLYING SKIN CHANGES. THE IMPLANTS WERE REMOVED AND ALCL COULD BE HISTOLOGICALLY CONFIRMED (CD30+, ALK-NEGATIVE". AFFECTED SIDE LEFT. DEVICE WAS EXPLANTED. "PATIENT ULTIMATELY TREATED WITH SURGICAL RESECTION, CHOP CHEMOTHERAPY, STEM CELL TRANSPLANT, BRENTUXIMAB, BUT PROGRESSED DESPITE THERAPY AND ULTIMATELY EXPIRED."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 674489 | UNK GEL BREAST IMPLANT | PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED | FTR | ALLERGAN (COSTA RICA) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 41 YR | Death| R |